Skip Navigation

European Heart Journal 1999 20(14):1039-1043; doi:10.1053/euhj.1999.1451
Copyright © 1999 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (55)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wallén, N.H.
Right arrow Articles by Hjemdahl, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wallén, N.H.
Right arrow Articles by Hjemdahl, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction

WallénN.H. a,f1, HeldC. b, RehnqvistN. c and HjemdahlP. a

a Department of Clinical Pharmacology, Karolinska Hospital, Stockholm, Sweden
b Department of Medicine, Danderyds Hospital, Stockholm, Sweden
c National Board of Health and Welfare, Stockholm, Sweden

revised November 10, 1998; accepted November 12, 1998

Abstract

Aims Inflammatory mechanisms have been implicated in the pathogenesis of atherosclerosis. Cell adhesion molecules, expressed on endothelial cells and leukocytes, mediate transendothelial migration of leukocytes into the vessel wall, but also circulate in soluble forms. In the present study we related soluble cell adhesion molecules to the risk of suffering a cardiovascular death or a non-fatal myocardial infarction (cardiovascular death/myocardial infarction) in a substudy to the Angina Prognosis Study in Stockholm (APSIS).

Methods and Results Soluble intercellular adhesion molecule-1, vascular adhesion molecule-1 and E-selectin were measured in serum collected on inclusion in the APSIS study. During follow-up, seven patients suffered non-fatal myocardial infarction or cardiovascular death, whereas 86 patients were event-free. Cardiovascular death/myocardial infarction was associated with elevated intercellular adhesion molecule-1 (354±142 vs 282±62ng.ml–1;P<0·01) and vascular adhesion molecule-1 (538±138 vs 433±135ng.ml–1;P=0·05), and E-selectin levels tended to be higher (72±54 vs 49±20ng.ml–1). Clinical risk factors (history of hypertension, previous myocardial infarction, diabetes and smoking) were more abundant in the event group. Subgroup analyses showed that hypertension, smoking or male sex were associated with elevated intercellular adhesion molecule-1, whereas previous myocardial infarction or male sex were associated with elevated vascular adhesion molecule-1.

Conclusion Patients with stable angina pectoris who developed cardiovascular death/myocardial infarction had elevated serum levels of soluble cell adhesion molecules, indicating increased inflammatory activity. The value of soluble cell adhesion molecules as prognostic markers in patients with stable ischaemic heart disease merits further study.

Key Words: Angina pectoris • intercellular adhesion molecule-1 • vascular adhesion molecule-1 • E-selectin

f1 Correspondence: Dr Han Wallén, Dept. of Clinical Pharmacology, Karolinska Hospital, S-171 76 Stockholm, Sweden


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CirculationHome page
L. M. Biasucci
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Clinical Use of Inflammatory Markers in Patients With Cardiovascular Diseases: A Background Paper
Circulation, December 21, 2004; 110(25): e560 - e567.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
J. Okapcova and D. Gabor
The Levels of Soluble Adhesion Molecules in Diabetic and Nondiabetic Patients with Combined Hyperlipoproteinemia and the Effect of Ciprofibrate Therapy
Angiology, November 1, 2004; 55(6): 629 - 639.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
J. Okapcova and D. Gabor
The Levels of Soluble Adhesion Molecules in Diabetic and Nondiabetic Patients with Combined Hyperlipoproteinemia and the Effect of Ciprofibrate Therapy
Angiology, November 1, 2004; 55(6): 629 - 639.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
Y. Cavusoglu, B. Timuralp, T. Us, Y. Akgun, G. Kudaiberdieva, B. Gorenek, A. Unalir, O. Goktekin, and N. Ata
Cigarette Smoking Increases Plasma Concentrations of Vascular Cell Adhesion Molecule-1 in Patients with Coronary Artery Disease
Angiology, July 1, 2004; 55(4): 397 - 402.
[Abstract] [PDF]


Home page
Biol Res NursHome page
L. Frazier
Novel Predictors of Acute Coronary Syndrome Outcomes
Biol Res Nurs, July 1, 2003; 5(1): 30 - 36.
[Abstract] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
C. F. Maurus, D. Schmidt, M. K.J. Schneider, M. I. Turina, J. D. Seebach, and G. Zund
Hypoxia and reoxygenation do not upregulate adhesion molecules and natural killer cell adhesion on human endothelial cells in vitro
Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 976 - 983.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Haim, D. Tanne, V. Boyko, T. Reshef, U. Goldbourt, J. Leor, Y. A. Mekori, and S. Behar
Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease: Data from the Bezafibrate Infarction Prevention (BIP) Study
J. Am. Coll. Cardiol., April 3, 2002; 39(7): 1133 - 1138.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Calabresi, M. Gomaraschi, B. Villa, L. Omoboni, C. Dmitrieff, and G. Franceschini
Elevated Soluble Cellular Adhesion Molecules in Subjects With Low HDL-Cholesterol
Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 656 - 661.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
I. Glurich, S. Grossi, B. Albini, A. Ho, R. Shah, M. Zeid, H. Baumann, R. J. Genco, and E. De Nardin
Systemic Inflammation in Cardiovascular and Periodontal Disease: Comparative Study
Clin. Vaccine Immunol., March 1, 2002; 9(2): 425 - 432.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. M. Herrington, K. B. Brosnihan, B. E. Pusser, E. W. Seely, P. M. Ridker, N. Rifai, and D. B. MacLean
Differential Effects of E and Droloxifene on C-Reactive Protein and Other Markers of Inflammation in Healthy Postmenopausal Women
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4216 - 4222.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
A. Yildirir, S. L. Tokgozoglu, I. Haznedaroglu, I. Sinici, G. Kabakci, K. Ovunc, S. Aksoyek, A. Oto, F. Ozmen, S. Kirazli, et al.
Extent of Coronary Atherosclerosis and Homocysteine Affect Endothelial Markers
Angiology, September 1, 2001; 52(9): 589 - 596.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Aljada, R. Garg, H. Ghanim, P. Mohanty, W. Hamouda, E. Assian, and P. Dandona
Nuclear Factor-{{kappa}}B Suppressive and Inhibitor-{{kappa}}B Stimulatory Effects of Troglitazone in Obese Patients with Type 2 Diabetes: Evidence of an Antiinflammatory Action?
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3250 - 3256.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
N T Mulvihill, J B Foley, R T Murphy, R Curtin, P A Crean, and M Walsh
Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules
Heart, June 1, 2001; 85(6): 623 - 627.
[Abstract] [Full Text]


Home page
ChestHome page
H. Kern, R. Wittich, U. Rohr, W. J. Kox, and C. D. Spies
Increased Endothelial Injury in Septic Patients With Coronary Artery Disease
Chest, March 1, 2001; 119(3): 874 - 883.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
F Boomsma, P.J de Kam, G Tjeerdsma, A.H van Den Meiracker, and D.J van Veldhuisen
Plasma semicarbazide-sensitive amine oxidase (SSAO) is an independent prognostic marker for mortality in chronic heart failure
Eur. Heart J., November 2, 2000; 21(22): 1859 - 1863.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Aljada, R. Saadeh, E. Assian, H. Ghanim, and P. Dandona
Insulin Inhibits the Expression of Intercellular Adhesion Molecule-1 by Human Aortic Endothelial Cells through Stimulation of Nitric Oxide
J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2572 - 2575.
[Abstract] [Full Text]


Home page
BMJHome page
P. Murray, G Frampton, and P. Nelson
Cell adhesion molecules
BMJ, August 7, 1999; 319(7206): 332 - 334.
[Full Text]


Home page
J. Biol. Chem.Home page
M. Montagnani, I. Golovchenko, I. Kim, G. Y. Koh, M. L. Goalstone, A. N. Mundhekar, M. Johansen, D. F. Kucik, M. J. Quon, and B. Draznin
Inhibition of Phosphatidylinositol 3-Kinase Enhances Mitogenic Actions of Insulin in Endothelial Cells
J. Biol. Chem., January 11, 2002; 277(3): 1794 - 1799.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Calabresi, M. Gomaraschi, B. Villa, L. Omoboni, C. Dmitrieff, and G. Franceschini
Elevated Soluble Cellular Adhesion Molecules in Subjects With Low HDL-Cholesterol
Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 656 - 661.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.